tallózása szerző szerint "Nagler A"

1-2 / 2

Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT.

Czerw T; Labopin M; Giebel S; Socie G; Volin L; Fegueux N; Masszi, Tamás; Blaise D; Chaganti S; Cornelissen JJ; Passweg J; Maertens J; Itala-Remes M; Wu D; Mohty M; Nagler A (2018)

BACKGROUND: Mobilized peripheral blood stem cells are currently the predominant source of grafts for allogeneic transplantation (allogeneic peripheral blood stem cell transplantation [allo-PBSCT]), although, in comparison ...
Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT

Giebel S; Labopin M; Potter M; Poire X; Sengeloev H; Socie G; Huynh A; Afanasyev BV; Schanz U; Ringden O; Kalhs P; Beelen DW; Campos AM; Masszi, Tamás; Canaani J; Mohty M; Nagler A (2018)

Background: Allogeneic haematopoietic stem cell transplantation (alloHSCT) is considered a standard treatment for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) achieving complete ...

1-2 / 2

Keresés